AMHR2
protein-codinganti-Mullerian hormone receptor type 2, the group of Type 2 receptor serine/threonine kinases
Gene summary
This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009857
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0009857
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009857
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009857
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009857
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Genitourinary; Oncologic
Intervention: Endocrine; Oncologic; Genitourinary
Rationale: In males, recognition can allow surveillance and surgical explorations to correct manifestations such as cryptorchdisim, which can be important to preserve fertility and decrease the chance of related sequelae (eg, testicular tumors)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AMHR2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020547.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 17 | 2 | 20 | ||
| missense | 2 | 12 | 77 | 8 | 99 | |
| nonsense | 7 | 4 | 11 | |||
| start loss | 1 | 1 | ||||
| frameshift | 8 | 5 | 13 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 1 | 5 | ||
| Total | 20 | 23 | 79 | 25 | 2 | 149 |
Highest pathogenic variant AF is 0.00038532782
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_065434.1 | 11 | MANE Select | |
| Ensembl | ENSP00000257863.3 | 11 | MANE Select | |
| RefSeq | NP_001158162.1 | 11 | Standard | |
| RefSeq | NP_001158163.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- TGF-beta signaling pathway - Homo sapiens (human)
- Cytokine-cytokine receptor interaction - Homo sapiens (human)
- TGF-Core
- Signal Transduction
- TGF-beta super family signaling pathway canonical
Biological Process
- Mullerian duct regression
- protein phosphorylation
- transforming growth factor beta receptor signaling pathway
- pattern specification process
- sex differentiation
Molecular Function
- transforming growth factor beta-activated receptor activity
- transforming growth factor beta receptor activity, type II
- protein binding
- ATP binding
- growth factor binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- receptor complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000257863
- Coding exons
- 11
- Length
- 7680
- Individuals with no LoFs
- 125683
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 65
- Defined
- 125748
- p
- 0.000258
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.394 | 293 | 313 | 0.937 | 0.0000180 | 3651 |
| Missense (PolyPhen) | 27 | 38.006 | 0.71041 | 476 | ||
| Synonymous | 1.05 | 108 | 123 | 0.879 | 0.00000588 | 1243 |
| Loss of Function | 1.85 | 20 | 31.1 | 0.643 | 0.00000218 | 280 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00080 | 0.00080 | rare |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.000099 | 0.000092 | rare |
| European (Non-Finnish) | 0.00024 | 0.00024 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone.;
- Disease
- DISEASE: Persistent Muellerian duct syndrome 2 (PMDS2) [MIM:261550]: A form of male pseudohermaphroditism characterized by a failure of Muellerian duct regression in otherwise normal males. {ECO:0000269|PubMed:11549681, ECO:0000269|PubMed:8872466}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- LoFtool
- 0.206
- RVIS EVS
- -0.93
- RVIS percentile EVS
- 9.47
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.964
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |